Literature DB >> 19026934

Hypothalamic control of hepatic glucose production and its potential role in insulin resistance.

Christoph Buettner1, Raul C Camacho.   

Abstract

The liver plays a pivotal role in the regulation of glucose metabolism because it is the key organ that maintains glucose levels during fasting. An emerging body of literature has demonstrated the important role of the hypothalamus in controlling hepatic glucose production (HGP). The hypothalamus senses circulating nutrients and hormones, conveying the energy status to the central nervous system, which, in turn, controls HGP in part by way of the autonomic nervous system. Overfeeding results in the failure of the hypothalamus to sense circulating nutrients and hormones, and in a loss of the central control of HGP.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19026934     DOI: 10.1016/j.ecl.2008.09.001

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  10 in total

1.  Brain insulin controls adipose tissue lipolysis and lipogenesis.

Authors:  Thomas Scherer; James O'Hare; Kelly Diggs-Andrews; Martina Schweiger; Bob Cheng; Claudia Lindtner; Elizabeth Zielinski; Prashant Vempati; Kai Su; Shveta Dighe; Thomas Milsom; Michelle Puchowicz; Ludger Scheja; Rudolf Zechner; Simon J Fisher; Stephen F Previs; Christoph Buettner
Journal:  Cell Metab       Date:  2011-02-02       Impact factor: 27.287

Review 2.  Hypothalamic control of energy and glucose metabolism.

Authors:  Stephanie Sisley; Darleen Sandoval
Journal:  Rev Endocr Metab Disord       Date:  2011-09       Impact factor: 6.514

Review 3.  Yin and Yang of hypothalamic insulin and leptin signaling in regulating white adipose tissue metabolism.

Authors:  Thomas Scherer; Christoph Buettner
Journal:  Rev Endocr Metab Disord       Date:  2011-09       Impact factor: 6.514

4.  Molecular characterization of insulin-mediated suppression of hepatic glucose production in vivo.

Authors:  Christopher J Ramnanan; Dale S Edgerton; Noelia Rivera; Jose Irimia-Dominguez; Ben Farmer; Doss W Neal; Margaret Lautz; E Patrick Donahue; Catalina M Meyer; Peter J Roach; Alan D Cherrington
Journal:  Diabetes       Date:  2010-02-25       Impact factor: 9.461

Review 5.  Hypothalamic-autonomic control of energy homeostasis.

Authors:  Patricia Seoane-Collazo; Johan Fernø; Francisco Gonzalez; Carlos Diéguez; Rosaura Leis; Rubén Nogueiras; Miguel López
Journal:  Endocrine       Date:  2015-06-19       Impact factor: 3.633

Review 6.  Molecular mechanisms for insulin resistance in treated HIV-infection.

Authors:  Paul W Hruz
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2011-06       Impact factor: 4.690

Review 7.  The dysregulation of the endocannabinoid system in diabesity-a tricky problem.

Authors:  Thomas Scherer; Christoph Buettner
Journal:  J Mol Med (Berl)       Date:  2009-03-17       Impact factor: 4.599

8.  Brain insulin lowers circulating BCAA levels by inducing hepatic BCAA catabolism.

Authors:  Andrew C Shin; Martin Fasshauer; Nika Filatova; Linus A Grundell; Elizabeth Zielinski; Jian-Ying Zhou; Thomas Scherer; Claudia Lindtner; Phillip J White; Amanda L Lapworth; Olga Ilkayeva; Uwe Knippschild; Anna M Wolf; Ludger Scheja; Kevin L Grove; Richard D Smith; Wei-Jun Qian; Christopher J Lynch; Christopher B Newgard; Christoph Buettner
Journal:  Cell Metab       Date:  2014-10-09       Impact factor: 27.287

9.  Central endocannabinoid signaling regulates hepatic glucose production and systemic lipolysis.

Authors:  James D O'Hare; Elizabeth Zielinski; Bob Cheng; Thomas Scherer; Christoph Buettner
Journal:  Diabetes       Date:  2011-04       Impact factor: 9.461

10.  Inhibition of hypothalamic inflammation reverses diet-induced insulin resistance in the liver.

Authors:  Marciane Milanski; Ana P Arruda; Andressa Coope; Letícia M Ignacio-Souza; Carla E Nunez; Erika A Roman; Talita Romanatto; Livia B Pascoal; Andrea M Caricilli; Marcio A Torsoni; Patricia O Prada; Mario J Saad; Licio A Velloso
Journal:  Diabetes       Date:  2012-04-20       Impact factor: 9.461

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.